<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20211011052727N3</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-04-10</date_registration>
      <primary_sponsor>Khyber Medical University</primary_sponsor>
      <public_title>Effectiveness of motor imagery on hemiplegic gait and walking energy cost in sub-acute stroke patients</public_title>
      <acronym></acronym>
      <scientific_title>Effectiveness of motor imagery on hemiplegic gait and walking energy cost in sub-acute stroke patients</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-04-15</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>32</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/64500</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: After meeting the inclusion criteria and giving a written informed consent, a total of 44 patients will be enrol in this study. These participants will be randomly allocated into two groups namely; the Experimental group (motor imagery along with conventional therapy) and the Control group (conventional therapy only). The random allocation will be performed by using sealed envelope (opaque). Total 44 envelopes will be made, 22 will be having a paper with group A (control group) written on it and 22 will have group B (experimental group). This will be for equal distribution of subjects in the two groups. Each participant will be asked to pick an envelope and will handed over to the researcher. Participants will not be blinded about their allocation. All the participants will be inform about the goals and intervention of the study by providing details, Blinding description: The outcome assessor who will be recording the outcome scores will be blinded he will not be aware weather the participant was in control group or experimental one.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Stroke rehabilitation.</hc_freetext>
      <i_freetext>Intervention 1: "Intervention group:" All the recruited patients in the interventional group will start each session with a mental rehearsal of the motor imagery technique for 15 minutes followed by 30 minutes of conventional physical therapy techniques including gait training exercises and Neuro-developmental techniques each session will last for 45 minutes. The patients will attend 3 sessions per week for a total of 6 weeks. The patient's baseline assessment includes walking speed, resting heart rate, oxygen saturation, and walking energy cost will be calculated using the physiological cost index. Intervention 2: Control group:   Patients in the control group will attend 45 minutes of conventional physical therapy techniques including gait training exercises and Neuro-developmental techniques each session will last for 45 minutes. The patients will attend 3 sessions per week for a total of 6 weeks. At the end of 6 weeks patient walking energy cost will be calculated by a blinded assessor.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is as this is the first trail on this case the initial plan is not to disclose it in the beginning.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Salman Farooqi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>264 F6, phase 6 hayatabad</address>
        <city>Hayatabad peshawar</city>
        <country1>Pakistan</country1>
        <zip>25001</zip>
        <telephone>+92 91 5823496</telephone>
        <email>Salman.farooqi@email.rmi.edu.pk</email>
        <affiliation>Khyber Medical University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Salman Farooqi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>264 F6, Phase 6 Hayatabad</address>
        <city>Hayatabad Peshawar</city>
        <country1>Pakistan</country1>
        <zip>25001</zip>
        <telephone>+92 91 5823496</telephone>
        <email>salman.farooqi@kmu.edu.pk</email>
        <affiliation>Khyber Medical University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Pakistan</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Mini mental state examination score&gt;24
Modified ashworth scale score&gt;3
Manual muscle testing &gt;3
Age between 40 - 75</inclusion_criteria>
      <agemin>40 years</agemin>
      <agemax>75 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Other neurological disorder excluded unstable acute stroke patient
Unilateral neglect
Cardiovascular patient
Cardiovascular patient
With evidence of flaccidity</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>G81</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Hemiplegia and hemiparesis</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>"Intervention group:" All the recruited patients in the interventional group will start each session with a mental rehearsal of the motor imagery technique for 15 minutes followed by 30 minutes of conventional physical therapy techniques including gait training exercises and Neuro-developmental techniques each session will last for 45 minutes. The patients will attend 3 sessions per week for a total of 6 weeks. The patient's baseline assessment includes walking speed, resting heart rate, oxygen saturation, and walking energy cost will be calculated using the physiological cost index.</i_keyword>
      <i_keyword>Control group:   Patients in the control group will attend 45 minutes of conventional physical therapy techniques including gait training exercises and Neuro-developmental techniques each session will last for 45 minutes. The patients will attend 3 sessions per week for a total of 6 weeks. At the end of 6 weeks patient walking energy cost will be calculated by a blinded assessor.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Physiological cost index. Timepoint: the outcome will be checked pre intervention then on 2nd and 4th week after intervention and finally on 6th week post intervention. Method of measurement: the formula to calculate the physiological cost index is exercising heart rate minus resting heart rate divided by walking velocity. ( heart rate will be recorded using a pulse oximeter and walking velocity will be measured using 6-meter walk test).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Khyber Medical University</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-06-20</approval_date>
        <contact_name>Institutionl ethical review committee. Institute of Physical Medicien and rehabilitation Khyber Medi</contact_name>
        <contact_address>Hayatabad phase 5 Peshawar Khyber pukhtoonkhwa Pakistan</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
